Trials / Sponsors / Regenera Pharma Ltd

Regenera Pharma Ltd

Industry · 6 registered clinical trials.

Status	Trial	Phase	Started
Terminated	Efficacy & Safety of RPh201 Treatment in Patients With Previous Nonarteritic Anterior Ischemic Optic Neuropath Nonarteritic Anterior Ischemic Optic Neuropathy	Phase 2	2018-07-10
Completed	A Clinical Study Evaluating the Efficacy and Safety of RPh201 Treatment in Individuals With Alzheimer's Diseas Mild to Moderate Dementia Due to Alzheimer's Disease, With or Without Coexisting Cerebrovascular Disease	Phase 2	2018-03-01
Completed	Safety and Efficacy Study of RPh201 Treatment of Ischemic Optic Neuropathy (ION). Non-arteritic Ischemic Optic Neuropathy, Optic Nerve Injuries	Phase 2	2014-02-01
Completed	A Randomized SAD and MAD Study Evaluating the Safety and Tolerability of RPh201 in Healthy Subjects and in Adu Healthy Volunteers, Moderate to Severe Alzheimer Patients	Phase 1 / Phase 2	2012-01-01
Terminated	Efficacy of RPh201 Applied Topically for the Treatment of Hard to Heal Chronic Ulcerated Wounds Chronic Wound	Phase 1 / Phase 2	2011-12-01
Withdrawn	Trial To Evaluate RPh201 In Treatment Of Partial Thickness Burn Second Degree Burn Less Than 5%TBSA, Partial Thickness Burn	Phase 1 / Phase 2	2011-12-01